Low Turnover Bone Disease

Oreopoulos D. , Robson M. , Izatt S. , Clayton S. , de Veber G. A simple and safe technique for continuous ambulatory peritoneal dialysis. Trans Am Soc Artif Intern Organs 1978; 24: 484–9.

Fassbinder W. , Brunner F. , Brynger H. Combined report on regular dialysis and transplantation in Europe, XX, 1989. Nephrol Dial Transplant 1991; 6(Suppl 1): 5–35.

Hutchison A. , Freemont A. , Boulton H. , Gokal R. Lowcalcium dialysis fluid and oral calcium carbonate in CAPD: a method of controlling hyperphosphataemia whilst minimizing aluminium exposure and hypercalcaemia. Nephrol Dial Transplant 1992; 7: 1219–25.

Slatopolsky E. , Weerts C. , Norwood K. Long-term effects of calcium carbonate and 2. 5 mEq/liter calcium dialysate on mineral metabolism. Kidney Int 1989; 36: 897–903.

Sherrard D. , Hercz G. , Pei Y The spectrum of bone disease in end-stage renal failure -an evolving disorder. Kidney Int 1993; 43: 436–42.

Moriniere P. , Cohen Solal A. , Belbrick S. Disappearance of aluminic bone disease in a long term asymptomatic dialysis population restricting AL(OH)3 intake: emergence of an idiopathic adynamic bone disease not related to aluminum. Nephron 1989; 53: 93–101.

Malluche H. , Monier-Faugere M. Risk of adynamic bone disease in dialyzed patients. Kidney Int 1992; 42(Suppl 38): 862–867.

Sherrard D. , Ott S. , Maloney N. , Andress D. , Coburn J. Renal osteody strophy: classification, cause and treatment. In: Frame B. , Potts J.J. eds. Clinical disorders of bone and mineral metabolism. Amsterdam: Excerpta Medica, 1983: 254–9.

Ott S. , Maloney N. , Coburn J. , Alfrey A. , Sherrard D. The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. N Engl J Med 1982; 307: 709–14.

Malluche H. , Faugere M. Renal bone disease 1990: an unmet challenge for the nephrologist. Kidney Int 1990; 38: 193–211.

Fournier A. , Moriniere P. , Cohen Solal M. Adynamic bone disease in uremia: May it be idiopathic? Is it an actual disease? Nephron 1991; 58: 1–12.

Quarles L. , Gitelman H. , Drezner M. Aluminium: cul pritor accessory in the genesis of renal osteodystrophy? Semin Nephrol 1986; 6: 90–101.

Hercz G. , Pei Y. , Manue I.A. Aplastic osteodystrophy without aluminum staining in dialysis patients (Abstract). Kidney Int 1990; 37: 449.

Cohen Solal M. , Sebert J. , Boudailliez B. Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients. J ClinEndocrinol Metab 1991; 73(3): 516–24.

Hutchison A. , Whitehouse R. , Boulton H. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int 1993; 44: 1071–7.

Marie P. , Lomri A. , de Vernejoul M. Relationships between histomorphometric features of bone formation and bone cell characteristics in vitro in renal osteodystrophy. J Clin Endocrinol Metab 1989; 69: 1166–73.

Kurz P. , Monier Faugere M. , Bognar B. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 1994; 46: 855–61.

Slatopolsky E. , Lopez-Hilker S. , Dusso A. , Brown A. , Morrissey J. , Martin K. The interrelationship between vitamin D and parathyroid hormone secretion in health and disease. In: Davison A. ed. Nephrology. London: Balliere Tindall, 1988: 1067–75.

Torres A. , Lorenzo V. , Hernandez D. Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. Kidney Int 1995; 47: 1434–42.

Vernon-Roberts B. , Pirie C. Healing trabecular microfractures in the bodies of lumbarvertebrae AnnRheum Dis 1973; 32: 406–12.

Moore P. , Hoyland J. Renal osteodystrophy: assessment of osteoblast function usingin situ hybridisation. J Am Soc Nephrol 1994; 5(3): 854.